作者:AN2 Therapeutics(ANTX)
发布于: | 公告 | 转发:0 | 回复:0 | 喜欢:0 |
$Athenex, Inc.(ANTX)$ 8-K - Current report Filed: 2018-11-14 AccNo: 0001193125-18-326088 Size: 88 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接